Open5.330 | Close- |
Vol / Avg.553.265K / 838.771K | Mkt Cap336.392M |
Day Range5.220 - 5.660 | 52 Wk Range4.570 - 21.050 |
Avid Bioservices Stock (NASDAQ: CDMO) stock price, news, charts, stock research, profile.
Open5.330 | Close- |
Vol / Avg.553.265K / 838.771K | Mkt Cap336.392M |
Day Range5.220 - 5.660 | 52 Wk Range4.570 - 21.050 |
Q2 2024 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.060 | (EXPECTED) 2023-12-07 | |||||
REV | 33.210M |
Q1 2024 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.030 | -0.030 | 0.0000 | ||||
REV | 36.090M | 37.726M | 1.636M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-09-28 | William Blair | Max Smock | Initiates Coverage On | Market Perform | - | - | - |
2023-09-08 | RBC Capital | Sean Dodge | Maintains | OutperformOutperform | Lowers | 17.00 | 15.00 |
2023-06-22 | RBC Capital | Sean Dodge | Maintains | OutperformOutperform | Lowers | 20.00 | 17.00 |
2023-06-22 | Stephens & Co. | Jacob Johnson | Reiterates | OverweightOverweight | Lowers | 24.00 | 20.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
CDMO | Avid Bioservices | 0.76% | 336.4M |
IMNM | Immunome | 1.66% | 339.3M |
ORTX | Orchard Therapeutics | 0.12% | 369.6M |
KALV | KalVista Pharma | 4.93% | 322M |
PGEN | Precigen | -0.41% | 302.4M |
You can purchase shares of Avid Bioservices (NASDAQ: CDMO) through any online brokerage.
Other companies in Avid Bioservices’s space includes: Immunome (NASDAQ:IMNM), Orchard Therapeutics (NASDAQ:ORTX), KalVista Pharma (NASDAQ:KALV), Precigen (NASDAQ:PGEN) and Celcuity (NASDAQ:CELC).
The latest price target for Avid Bioservices (NASDAQ: CDMO) was reported by William Blair on Thursday, September 28, 2023. The analyst firm set a price target for 0.00 expecting CDMO to fall to within 12 months (a possible -100.00% downside). 8 analyst firms have reported ratings in the last year.
The stock price for Avid Bioservices (NASDAQ: CDMO) is $5.33 last updated Today at December 6, 2023 at 5:34 PM UTC.
There is no dividend information for Avid Bioservices.
Avid Bioservices’s Q2 earnings are confirmed for Thursday, December 7, 2023.
There is no upcoming split for Avid Bioservices.
Avid Bioservices is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.